Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
85.3M
-
Shares change
-
+4.03M
-
Total reported value, excl. options
-
$2.21B
-
Value change
-
+$96.8M
-
Put/Call ratio
-
0.59
-
Number of buys
-
86
-
Number of sells
-
-90
-
Price
-
$25.94
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2018
220 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q4 2018.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.3M shares
of 183M outstanding shares and own 46.53% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (8.42M shares), FMR LLC (8.03M shares), Vanguard Group Inc (6.31M shares), JANUS HENDERSON GROUP PLC (5.44M shares), BAKER BROS. ADVISORS LP (5.02M shares), BlackRock Inc. (4.91M shares), WELLINGTON MANAGEMENT GROUP LLP (4.58M shares), STATE STREET CORP (3.49M shares), Rubric Capital Management LP (2.79M shares), and CITADEL ADVISORS LLC (2.64M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.